American Pathway Fixed Annuity II 5-Year review

Yes, for the narrow purpose it's built for. If you want a five-year guaranteed rate with no market exposure and don't need an income rider or a bonus, this is a competent option — the rate banding is reasonable, the death benefit passes cleanly to a beneficiary, and the built-in chronic illness and terminal illness waivers add real value at no cost. It's not a good fit if you want the single highest rate available in the five-year MYGA market, since 4.85% (soon 5.00%) at the top band is respectable but not exceptional, or if you think you might need more than 10% of your money before the term ends.

The main reason to buy this contract is certainty: a fixed rate, locked for five years, with none of the complexity of an indexed or variable product. The secondary reason is the built-in health-related access — the Extended Care and Terminal Illness waivers let you get to your full account value without a surrender charge or MVA if you're diagnosed with a qualifying condition, and that protection comes free. In practical terms, this is the annuity someone buys when they've already decided they want a MYGA and are comparing rate sheets rather than shopping for features.

I think this product is best for someone in or near retirement who has a defined five-year time horizon for a portion of their savings — money they're confident they won't need beyond the 10% annual free-withdrawal amount — and who wants a guaranteed rate rather than index-linked upside. It also suits someone specifically drawn to the no-cost chronic illness and terminal illness waivers as a form of self-insurance against long-term care costs. It's a weaker fit for someone who wants the maximum possible free-withdrawal flexibility (some sibling Corebridge MYGAs offer 15-20%) or someone chasing the single best rate in the market, since $25,000 only buys the lower rate band here.

You're not buying an investment in the market sense. You're buying an insurance company's promise to pay a fixed rate of interest on your deposit for five years, backed by Corebridge's general account and A.M. Best's A rating on the issuing entity, American General Life Insurance Company. After the five-year guarantee period ends, the rate resets annually at whatever Corebridge is then crediting — so the "deal" you're locking in is really just the first five years, not the life of the contract. The value here is predictability: no caps, no participation rates, no index performance to track, just a stated rate that doesn't move for five years.

The current fixed account rate is 4.60% for deposits under $100,000 and 4.85% for deposits of $100,000 or more, guaranteed for the full five-year term. Corebridge has already scheduled an increase to 4.75%/5.00% effective May 11, 2026, which is a reminder that these figures are snapshots — rates on a new MYGA purchase move with the broader interest-rate environment, and the number you'd actually get depends on when you apply. Whichever rate you lock in, it holds steady for the entire surrender period; you aren't exposed to rate cuts mid-term, but you also don't benefit if rates rise significantly before your term is up.

The built-in Extended Care and Terminal Illness waivers are the most meaningful secondary feature here, mostly because they cost nothing extra. If you're diagnosed with a qualifying chronic or terminal condition, you can access your account value without triggering the surrender charge or the MVA — a real form of downside protection that many competing MYGAs charge for or omit entirely. It doesn't replace long-term care insurance, but it does mean this contract won't trap your money behind a penalty wall at the exact moment you might need it most.

You're trading five years of full liquidity for a locked rate. The surrender schedule starts at 7% in year one and steps down to 3% by year five (7%, 6%, 5%, 4%, 3%), and a market value adjustment also applies to withdrawals above the free amount during that window — so an early exit can cost you more or less than the stated surrender charge depending on where interest rates have moved since you bought the contract. The free-withdrawal provision lets you take out 10% of the previous year's anniversary value annually after the first contract year with no charge or MVA, as long as you leave at least $2,000 in the account. RMDs tied specifically to this contract are exempt from both the surrender charge and the MVA at any time, which matters if this is qualified money. The chronic illness and terminal illness waivers add another layer of penalty-free access if a qualifying health event occurs.

There's no explicit rider fee here — the brochure materials don't show a base contract fee, and the chronic illness and terminal illness waivers are built in at no additional cost, which is a genuine plus for a product at this price point. The real tradeoff isn't a fee line item; it's structural. The 10% free-withdrawal cap is narrower than some Corebridge siblings that allow 15-20%, and the MVA means a forced early exit in a rising-rate environment could cost you more than the stated surrender percentage. The Minimum Guaranteed Surrender Value floor — 87.5% of premium at 0.15%-3% — sets the worst-case outcome if you surrender early, and it's a standard, unremarkable floor for this product category.

Legal Entity: American General Life Insurance Company

Parent: Corebridge Financial

A.M. Best Rating: A